← FDA Drug Approvals (Drugs@FDA)
IMJUDO
BLA · Biologics License Application · Sponsor: ASTRAZENECA AB · Approved 2022-10-21
Drug application
- FDA Application #
BLA761289- Application type
- Biologics License Application
- Brand name
- IMJUDO
- Generic name
- TREMELIMUMAB
- Active ingredients
- TREMELIMUMAB-ACTL
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- ASTRAZENECA AB
- Manufacturer
- AstraZeneca Pharmaceuticals LP
- First approval
- 2022-10-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown